Supplementary File

Title Fig. 8. The effectiveness of vedolizumab in UC after 12 months of therapy, depending on the response to hormone therapy.
Submission Vedolizumab in patients with inflammatory bowel diseases of in real clinical practice
Type
Date 2020-04-26

Supplementary File

File Name 33909-57423-1-SP.JPG
Original file name 11-8.JPG
File Size 46KB
Date uploaded 26.04.2020 23:48